Reagents & Consumables held the largest position in the peptide synthesis market in 2025, accounting for a 50.85% share. This leadership is maintained through the recurring nature of peptide synthesis workflows, where amino acids, resins, solvents, coupling agents, and purification-related consumables are used continuously across research and production activities. Unlike equipment, which is purchased less frequently, reagents and consumables generate steady demand because every synthesis cycle depends on consistent material input, making this segment central to routine laboratory and manufacturing operations in the peptide synthesis market.

Equipment is the fastest-growing segment in the peptide synthesis market as laboratories and manufacturers increasingly prioritize process efficiency, reproducibility, and scale-up capability. Growth is being underpinned by the need to handle more complex peptide production with tighter control over reaction conditions and workflow automation than manual or less integrated setups can offer. Compared with consumables, equipment is gaining momentum because investment is tied to capacity expansion and modernization efforts, especially where users seek to improve throughput and reduce operational variability in peptide synthesis.

Technology Segment Analysis: Liquid Phase Peptide Synthesis (LPPS) (Largest Segment) vs Hybrid Technology (Fastest-Growing Segment)

In 2025, Liquid Phase Peptide Synthesis (LPPS) led the peptide synthesis market with a 46.68% share. Its dominant position is underpinned by established use in peptide production environments where process familiarity, proven reaction handling, and suitability for certain synthesis and purification workflows remain important. LPPS continues to maintain leadership in the peptide synthesis market because users value well-understood operational methods that align with existing laboratory practices and production infrastructure, helping preserve demand across ongoing synthesis applications.

Hybrid Technology is emerging as the fastest-growing segment in the peptide synthesis market because it addresses practical limitations associated with relying on a single synthesis approach. Its momentum comes from the ability to combine process advantages in ways that improve flexibility, efficiency, and applicability for more demanding peptide development needs. Relative to conventional standalone methods, hybrid technology is experiencing stronger uptake where users need better workflow adaptability and stronger performance across varied peptide synthesis requirements.